Reclassification of Nexium Control 20mg Gastro-Resistant Tablets

Nexium Control 20mg Tablets is a medicine to be taken by mouth for the short term (up to 14 days) treatment of reflux symptoms (eg heartburn and acid regurgitation) in adults.

The Medicines and Healthcare products Regulatory Agency (MHRA) considers this product is safe enough to be sold on general sale. This report outlines the evidence that the MHRA reviewed which led to the decision to approve the application.

This report presents the evidence that was available when the regulatory decision was made, showing a ‘snapshot’ of the clinical landscape at the time. However, any advice in this report remains current unless it is superseded by a more recent report (where relevant, this is indicated).

Public assessment report - reclassification of Nexium Control 20mg Gastro-Resistant TabletsPDF file (opens in new window) (106Kb)

Page last modified: 11 February 2016